Ureaplasma Urealyticum Parvum Recombinant Protein
Recombinant Ureaplasma Urealyticum Parvum
Applications
ELISA
Purity
Greater than 95% as determined by 10% PAGE (Coomassie staining).The recombinant fusion protein was purified by GSH affinity chromatography technique.
Synonyms
Ureaplasma Urealyticum Parvum; Recombinant Ureaplasma Urealyticum Parvum; U. Urealyticum; Ureaplasma Urealyticum Parvum Recombinant; U. urealyticum; UreD; MB Antigen; Ureaplasma Urealyticum Parvum recombinant protein
Host
E Coli
Purity/Purification
Greater than 95% as determined by 10% PAGE (Coomassie staining).
The recombinant fusion protein was purified by GSH affinity chromatography technique.
The recombinant fusion protein was purified by GSH affinity chromatography technique.
Form/Format
MB Antigen (2.2 mg/ml) is formulated in 1x PBS and 1mM EDTA pH 7.4 and 0.01% Sodium azide.
Sterile filtered colorless solution.
Sterile filtered colorless solution.
Applicable Applications for Ureaplasma Urealyticum Parvum recombinant protein
ELISA (EIA)
Application Notes
Can be used for lateral follow product, ELISA assay and vaccine development.
Preparation and Storage
Upon arrival, Store at -20 degree C. Please prevent freeze-thaw cycles.
Related Product Information for Ureaplasma Urealyticum Parvum recombinant protein
Description: MB antigen of Ureaplasma parvum serovar fused with GST, is expressed in E Coli, having a Mw of 40kDa, and recognized by the specific IgM anf IgG to Ureaplasma parvum.
Introduction: Ureaplasma urealyticum parvum is a pathogenic mycoplasma localized in genito-urinary tracts, Ureaplasma urealyticum parvum is one of the smallest free living organisms and the only organism expressing human immuno-globulin A1 protease to decompose human protective antibody. Ureaplasma parvum is realted with various diseases, causing male urethritis, pyelonephritis, chorioamnionitis, pelvic inflammation, infertility via placental inflammation and abnormal outcomes during the early infection of pregnancy via amniotic sac, other diseases include supperative arthritis, surgical infections, neonatal meningitis and neonatal disease. Lower respiratory infection is also very common for preterm infants and low birth weight baby. Which usually lead to bronco pulmonary dysplasia and congenital pneumonia, meningitis, and even death. MB antigen is considered as a major antigen of Ureaplasma parvum, it is preent in different clinical isolates.
Introduction: Ureaplasma urealyticum parvum is a pathogenic mycoplasma localized in genito-urinary tracts, Ureaplasma urealyticum parvum is one of the smallest free living organisms and the only organism expressing human immuno-globulin A1 protease to decompose human protective antibody. Ureaplasma parvum is realted with various diseases, causing male urethritis, pyelonephritis, chorioamnionitis, pelvic inflammation, infertility via placental inflammation and abnormal outcomes during the early infection of pregnancy via amniotic sac, other diseases include supperative arthritis, surgical infections, neonatal meningitis and neonatal disease. Lower respiratory infection is also very common for preterm infants and low birth weight baby. Which usually lead to bronco pulmonary dysplasia and congenital pneumonia, meningitis, and even death. MB antigen is considered as a major antigen of Ureaplasma parvum, it is preent in different clinical isolates.
Product Categories/Family for Ureaplasma Urealyticum Parvum recombinant protein
Similar Products
Product Notes
The Ureaplasma Urealyticum Parvum (Catalog #AAA144121) is a Recombinant Protein produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. AAA Biotech's Ureaplasma Urealyticum Parvum can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). Can be used for lateral follow product, ELISA assay and vaccine development. Researchers should empirically determine the suitability of the Ureaplasma Urealyticum Parvum for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "Ureaplasma Urealyticum Parvum, Recombinant Protein" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
